Journals / Türk Hijyen ve Deneysel Biyoloji Dergisi / 2017 / Cilt: 74 Sayı: 3

Investigation of Toxoplasmosis in patients prediagnosed as lymphadenopathy in Hitit University Corum Training and Research Hospital

Hitit Üniversitesi Corum Eğitim ve Araştırma Hastanesi’nde Lenfadenopati Ön Tanılı Olguların Toksoplazmoz Açısından İrdelenmesi

Pages
237–242
Publication Date
2017-09-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

With this purpose, training about differential diagnosis and serology of toxoplasmosis is recommended for the clinicians who take part in management of LAP cases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Localized lymphadenopathy LAP is the most common symptomatic form of toxoplasmosis which usually seen as asymptomatic in healthy population.
📊
Key Findings & Data:Methods: Two hundred and thirty nine patients 57.7% female, 42.3% male with the preliminary diagnosis of LAP, were admitted to Infectious Diseases and Clinical Microbiology Clinic of Hitit University Corum Training and Research Hospital between August 2013 and July 2015.
💡
Conclusion & Impact:With this purpose, training about differential diagnosis and serology of toxoplasmosis is recommended for the clinicians who take part in management of LAP cases.
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Toksoplazmoz · lenfadenopati · tanı

Abstract

Objective: Localized lymphadenopathy LAP is the most common symptomatic form of toxoplasmosis which usually seen as asymptomatic in healthy population. In this study, we aimed to evaluate toxoplasmosis in patients with preliminary diagnosis of LAP. Methods: Two hundred and thirty nine patients 57.7% female, 42.3% male with the preliminary diagnosis of LAP, were admitted to Infectious Diseases and Clinical Microbiology Clinic of Hitit University Corum Training and Research Hospital between August 2013 and July 2015. Demographic, serological, radiological and pathological data were obtained from the hospital information system HIS . Toxoplasma IgG and IgM levels were studied by chemiluminescent microparticle enzyme immunoassay, using Architect Abbott Diagnostics or Cobas E 601 Roche Diagnostics . Results: None of the patients had immunosuppression. Fifty-one 36.96% of 138 women and 13 12.87% of 101 men were tested positive for IgG and/or IgM antibodies against Toxoplasma. Both in males 3.76% and in females 10.46% , the highest antibody positivity rates are detected in patients under 39 years of age. Only IgG, IgG and IgM, and only IgM positivity for toxoplasma was identified in 48 20.1% , 12 5% and, 4 1.7% patients, respectively. Seven 2.93% of 16 Toxoplasma IgM positive patients were women under 39 years of age. Only two of them were tested for IgG avidity, and both displayed high avidity. Ultrasound examination was performed for 12 patients with positive IgM results. The distribution of the LAP, including 6 multiple involvement, were as follows: 7 bilateral cervical, 5 submandibular, 3 parotid, 3 occipital, 1 submental, 1 retroauricular. The smallest LAP was measured as 6x5 mm and the largest one was of 24x12 mm. Fine needle aspiration biopsy were performed to 3 of anti-Toxoplasma IgM-positive patients. Lymphoid hyperplasia and chronic nonspecific lymphadenitis were observed in one, and two patients, respectively. Upon the initiation of an appropriate treatment in six patients with LAP and IgM positivity, a decline was observed in LAP sizes. Conclusion: As a result, 6.70% IgM positivity that we found in this study, indicates that toxoplasmosis should be considered by clinician in the etiology of LAP. With this purpose, training about differential diagnosis and serology of toxoplasmosis is recommended for the clinicians who take part in management of LAP cases.

Özet

Amaç: Sağlıklı insanlarda genellikle asemptomatik seyreden toksoplazmozun en sık görülen semptomatik formu lokalize lenfadenopati LAP ’dir. Bu çalışmada LAP ön tanısı ile başvuran hastaların toksoplazmoz açısından irdelenmesi amaçlanmıştır. Yöntem: 01.08.2013-31.07.2015 tarihleri arasında Hitit Üniversitesi Çorum Eğitim ve Araştırma Hastanesi Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Kliniği’ne LAP ön tanısı ile başvuran 239 %57,70 kadın, %42,30 erkek hastaya ait demografik, serolojik, radyolojik ve patolojik veriler hastane bilgi sisteminden HBS elde edilmiştir. Anti-Toxoplasma IgG ve IgM testleri Architect Abbott Diagnostics veya Cobas E 601 Roche Diagnostics cihazlarıyla kemilüminesan yöntemiyle çalışılmıştır.mikropartikül enzimimmünassay Bulgular: Hiçbirinde immunsupresyon hikayesi olmayan hastalardan 138 kadının 51 %36,96 ’inde, 101 erkeğin 13 %12,87 ’ünde IgG ve/veya IgM antikoru pozitifti. Hem erkeklerde %3,76 hem de kadınlarda %10,46 en yüksek antikor pozitiflik oranı 39 yaş altındadır. Hastaların 48 %20,10 ’inde yalnızca anti-Toxoplasma IgG, 12 %5 ’sinde ise IgG ve IgM birlikte ve dört %1,70 ’ünde ise tek başına IgM pozitifliği belirlenmiştir. Anti-Toxoplasma IgM’i pozitif 16 hastadan 7 %2,93 ’si 39 yaş altı kadın olup yalnızca ikisinde çalışılan IgG avidite testi yüksek avidite olarak bulunmuştur. IgM pozitif olan hastaların ultrasonografisine ulaşılan 12’sinde, altısında çoklu tutulum olmak üzere LAP’ların dağılımı şöyledir: yedi bilateral servikal, beş submandibular, üç parotis, 3 oksipital, bir submental, bir retroaurikular. LAP’ların en küçüğü 6x5 mm, en büyüğü ise 24x12 mm ebatlarındadır. Toksoplazmoz IgM pozitif hastalardan üçüne ince iğne aspirasyon biyopsisi yapılmış, birinde reaktif lenfoid hiperplazi, ikisinde kronik nonspesifik lenfadenit tespit edilmiştir. LAP ve IgM pozitif olan altı hastaya tedavi verildiği ve LAP’larında gerileme olduğu belirlenmiştir.Sonuç: Sonuç olarak çalışmamızda belirlediğimiz %6,70’lik IgM pozitifliği klinisyenlerin LAP etiyolojisinde toksoplazmozu akılda tutması gerekliliğini ortaya koymaktadır. Bu amaçla LAP incelemesinde yer alan hekimlere ayırıcı tanı ve toksoplazmozda serolojik tanının yeri konusunda eğitim verilmesi önerilir

🔖

Cite This Article

GÜRESER, A. S., YAPAR, D., TAŞÇI, L., BOYACIOĞLU, Z. İ., TURGAL, E., BAYKAM, N., ÖZKAN, A. T. (2017). Investigation of Toxoplasmosis in patients prediagnosed as lymphadenopathy in Hitit University Corum Training and Research Hospital. Türk Hijyen ve Deneysel Biyoloji Dergisi, Cilt: 74 Sayı: 3, 237–242. https://ajindex.com/articles/975553

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Gül M, Aliosmanoğlu İ, Türkoğlu A, Dal S, Ülger BV, Uslukaya Ö ve ark. Peripheral lymphadenopathy in adults: results of 67 cases of excisional biopsy. Dicle Med J, 2013; 40 (2): 245-9.
  2. Jones JL, Parise ME, Fiore AE. Neglected parasitic infections in the United States: toxoplasmosis. Am J Trop Med Hyg, 2014; 90 (5): 794-9.
  3. Sunay T, Süoğlu Y, Katırcıoğlu S, Ünal M, Ağan M. Baş-boyunda toksoplazma infeksiyonu. KBB ve BBC Derg, 1995; 3: 272-5.
  4. Cengiz SA, Cengiz L, Us E, Cengiz AT. Gebe kadınların serumlarında Rubella IgG ve IgM’nin ELISA ile araştırılması. İnfek Derg, 2005; 19 (1): 19-24.
  5. Cook AJ, Gilbert RE, Buolano W, Zufferey J, Petersen E, Jenum PA, et al. Sources of toxoplasma infection in pregnant women: european multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ, 2000; 321 (7254): 142-7.
  6. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet, 2004; 363 (9425): 1965-76. Pullukçu H. Toksoplazmoz. Türkiye’de görülen zoonotik hastalıklar: dağılım, tanı ve tedavide yenilikler özel sayısı. Turkiye Klinikleri J Inf Dis- Special Topics, 2015; 8 (2): 41-9.
  7. Yarıktaş M, Demirci M, Döner F, Kaya S, Doğru H. Baş-boyun bölgesi lenfoid hiperplazisi olan olgularda tokzoplazmosis. Kulak Burun Bogaz Ihtis Derg, 2004 (5-6); 13: 132-4.
  8. Aydil U, Özçelik T, Kutluay L. Parotis kitlesini taklit eden toksoplazma lenfadeniti. Kulak Burun Bogaz Ihtis Derg, 2010; 20 (2): 97-9.
  9. Montoya JG, Huffman HB, Remington JS. Evaluation of the immunoglobulin G avidity test for diagnosis of toxoplasmic lymphadenopathy. J Clin Microbiol, 2004; 42 (10): 4627-31.
  10. Durlach RA, Kaufer F, Carral L, Hirt J. Toxoplasmic lymphadenitis-clinical and serologic profile. Clin Microbiol Infect, 2003; 9 (7): 625-31.
  11. Bakacak M, Serin S, Aral M, Ercan Ö, Köstü B, Kireçci A ve ark. Seroprevalance differences of toxoplasma between Syrian refugees pregnants and indigenous Turkish pregnants in Kahramanmaraş. Turkiye Parazitol Derg, 2015; 39 (2): 94-7.
  12. Da Silva MG, Avelino MM, Amaral WN, de Castro AM. Optimizing the parasitological diagnosis of congenital toxoplasmosis. Universitas: Ciencias da Saude, 2013; 11: 75-81.
  13. Brooks RG, McCabe RE, Remington JS. Role of serology in the diagnosis of toxoplasmic lymphadenopathy. Rev Infect Dis, 1987; 9 (4): 775-82.
  14. Da Silva MG, Vinaud MC, de Castro AM. Prevalence of toxoplasmosis in pregnant women and vertical transmission of Toxoplasma gondii in patients from basic units of health from Gurupi, Tocantins, Brazil, from 2012 to 2014. PLoS One, 20